Admitted patients and may be used to
predict the prognosis of patients with septic shock. Sepsis is a complex
syndrome caused by the body’s systemic response to an infection with a major
cause of high treatment cost, single or multiple organ dysfunctions.[1-4] C-reactive protein (CRP) is also a useful positive
acute-phase reactant marker that can predict morbidity and mortality among
critically ill patients. [5,6] However, the results of CRP and other severity
indices of sepsis may not be immediately available upon request, potentially
delaying effective dynamic risk stratification and goal directed management in
these unstable studied cohort. MAP which defined as 1/3 SBP + 2/3 DBP is
a readily and affordable attained comprehensive parameter that combines two
physiological pressure parameters (SBP and DBP) into a single parameter and
previously has been shown to stratify and served as an early warning
prognosticator of high risk septic patients from various aetiologies when
compared to SBP and DBP.[7-10] Having reliable indicators and
markers that would help prognosticate the survival of these patients is
invaluable and would subsequently assist in the course of effective treatment.[11,12]
Our objective was to compare the ability of %DBP, %SBP, and %MAP variations to
predict the primary outcome of overall 28-day ICU mortality, and the secondary
outcomes of early mortality (≤14 days), late mortality (>14 days), and ICU length
of stay (LOS). Also, our objective was to determine the
optimal cut-off point, sensitivity (TPR), specificity (TNR), Youden’s index
(YI), positive and negative predictive values (PPV and NPV), and accuracy
index (AI), of the three tested prognosticators.
Methods
This was a single-centre observational
retrospective study conducted in the department of adult ICU of King Hussein
Medical Hospital (KHMH) at Royal Medical Services (RMS) in Jordan. This study
was approved by our Institutional Review Board (IRB), and a requirement for
consent was waived owing to its retrospective design. This study included a
cohort of 913 critically ill patients admitted to our adult ICU via the
emergency department (ED) or via other hospital wards with any medical or
surgical problems. After excluded all patients who were died or discharged
before completed at least 1 week after admission and included all critically
ill patients who their anthropometrics, diagnostics, demographics,
hemodynamics, nutritional indices, and all required laboratory data were known,
163 critically ill patients were finally included in our study. Flow chart of
critically ill patient’s selection and data collection process is fully
illustrated in Figure 1.
All patient continuous variables were
expressed as mean± standard deviation by using the independent samples T-test
while categorical and ordinal variables were expressed as numbers with
percentages by using the chi square test or as median (interquartile range) by
using the Mann-Whitney U test, respectively. Analysis values were compared for
the two tested groups (survivors vs. non-survivors) and the non-survival group
was further analysed after being divided into 2 subgroups, early (≤14 days) and
late (>14 days) mortality. A receiver operating
characteristic (ROC) curve followed by sensitivity analysis was used to
determine the area under the ROC curves (AUROCs), predictive performances, and
the optimal cut-off values for %SBPvar, %MAPvar, and %DBPvar,
YI, TPR, TNR, PPV, NPV, and AI were also calculated. Statistical analyses
were performed using IBM SPSS ver. 25 (IBM Corp., Armonk, NY, USA) and P-values
≤0.05 were considered statistically significant.
Result
The mean overall age was 58.37±9.96 years. 112
subjects (68.71%) were male and 51 subjects (31.29%) were female. The overall
28-day, early, and late ICU mortality rate were 39.26% (64 patients), 9.82% (16 patients), and 29.45% (48 patients),
respectively. 28-day ICU mortality was
significantly higher in medically than surgically admitted patients (85.94% (55 medically patients) versus 14.06% (9 surgically patients),
respectively). Baseline pre-ICU admission
days and number of co-morbidities >1 were also significantly higher in
non-survivors than survivors (7.42±4.57 days versus 2.23±1.06 days and 65.63% (42 subjects) versus 47.47% (47 subjects), respectively). Despite baseline albumin level (ALB1)
was significantly higher in non-survivors (2.94±0.39 g/dl) than survivors (2.63±0.20 g/dl), survivors had significantly higher
average administered human albumin (H.ALB) doses and nutritional protein
density (PD) inputs and significantly lower CRP (18.89±3.16 g/day and 3.72±0.74 g/100 Cal
and 28.38±14.38 mg/dl, respectively) than non-survivors (14.06±6.09 g/day and 3.50±0.36 g/100 Cal
and 43.09±19.28 mg/dl, respectively) which ultimately resulted in significantly higher
average ALB during ICU admission in survivors (2.87±0.12 g/dl) than in non survivors
(2.57±0.13 g/dl).
The ICU and overall hospital LOS were also significantly lower in survivors non
survivors (9.23±1.06 days and 11.46±2.12
days versus 17.30±4.14 days and 24.72±1.98
days, respectively).
Table I: Demographics
and anthropometrics comparison of study’s critically ill patients.
|
Variables
|
Total
(N=163)
|
Survivors
(N=99 )
|
Non-survivors
(N=64)
|
P-Value
|
Early
Mortality
(≤14
days)
(N=16)
|
Late
Mortality (>14 days)
(N=48)
|
Age (Yrs)
|
58.37±9.96
|
58.55±9.948
|
58.09±10.053
|
0.92
(NS)
|
62.31±11.12
|
56.69±9.38
|
Gender
|
Male
|
112 (68.71%)
|
67 (67.68%)
|
45 (70.31%)
|
0.79
(NS)
|
11 (68.75%)
|
34 (70.83%)
|
Female
|
51 (31.29%)
|
32 (32.32%)
|
19 (29.69%)
|
5 (31.25%)
|
14 (29.17%)
|
Day(s)
Pre-ICU admission (day(s))
|
4.27±3.91
|
2.23±1.06
|
7.42±4.57
|
0.00
(S)
|
13.31±5.89
|
5.46±1.10
|
ICU Stay
day(s)
|
12.40±4.79
|
9.23±1.06
|
17.30±4.14
|
0.00
(S)
|
10.56±1.97
|
19.54±1.10
|
Hospital
Stay day(s)
|
16.67±6.81
|
11.46±2.12
|
24.72±1.98
|
0.00
(S)
|
23.87±3.93
|
25.00±0.00
|
Number of
comorbidities
|
0, 1
|
74 (45.39%)
|
52 (52.53%)
|
22 (34.38%)
|
0.03
(NS)
|
3 (18.75%)
|
19 (39.58%)
|
2 , 3, 4+
|
89 (54.60%))
|
47 (47.47%)
|
42 (65.63%)
|
13 (81.25%)
|
29 (60.42%)
|
Admission
class
|
Medical
|
105 (64.42%)
|
50 (50.51%)
|
55 (85.94%)
|
0.00
(S)
|
14 (87.5%)
|
41 (85.42%)
|
Surgical
|
58 (35.58%)
|
49 (49.49%)
|
9 (14.06%)
|
2 (12.5%)
|
7 (14.58%)
|
BW1
(Kg)
|
74.17±10.24
|
74.63±10.06
|
73.45±10.56
|
0.61
(NS)
|
69.44±9.34
|
74.79±10.69
|
BMI1
(Kg/m²)
|
25.92±4.00
|
26.19±3.85
|
25.50±4.22
|
0.31
(NS)
|
24.11±4.28
|
25.97±4.14
|
28-day
ICU Survival
|
99
(60.74%)
|
28-day
ICU Mortality
|
Overall
Mortality
|
64
(39.26%)
|
Early
Mortality (≤14 days)
|
16
(9.82%)
|
Late
Mortality (>14 days)
|
48
(29.45%)
|
Values are presented as
mean±standard deviation using one sample T-test and independent T-test or as number
(%) using chi square test.
|
Yrs: Years.
Kg: Kilogram.
m: Meter.
BW1: Actual body
weight at admission.
BMI1: Body mass
index at admission.
|
ICU: Intensive care unit.
S: Significant (P-Value
<0.05).
NS: Non-significant (P-Value
>0.05).
N: Number of study’s
critically ill patients.
|
All haemodynamic parameters of SBPmax,
SBPmin, and SBPavg versus MAPmax, MAPmin,
and MAPavg versus DBPmax, DBPmin, and DBPavg
versus were significantly higher values in survivors (113.77±3.15 mmHg, 103.77±3.15 mmHg, and 111.77±3.15 mmHg versus
87.04±3.16 mmHg, 73.77±3.15 mmHg, and 81.77±3.15 mmHg versus 73.44±3.30 mmHg,
58.64±3.23 mmHg, and 66.65±3.20 mmHg, respectively) than in
non-survivors (98.41±16.13 mmHg, 88.41±16.13 mmHg, and 96.41±16.13
mmHg versus 72.14±14.81 mmHg, 58.99±13.98 mmHg, and 66.76±14.70 mmHg
versus 57.26±17.02 mmHg, 42.99±16.46
mmHg, and 51.03±16.47 mmHg, respectively).
Table II: Follow-up
data comparison of study’s critically ill patients.
|
Variables
|
Total
(N=163)
|
Survivors
(N=99 )
|
Non-survivors
(N=64)
|
P-Value
|
Early
Mortality
(≤14
days)
(N=16)
|
Late
Mortality
(>14
days)
(N=48)
|
NE (mcg/min)
|
9.53±1.79
|
9.27±1.68
|
9.94±1.89
|
0.72
(NS)
|
9.94±2.49
|
9.94±1.67
|
GCS (3-15)
|
12
(12-13)
|
12
(12-13)
|
12 (12-13)
|
0.34
(NS)
|
12 (12-13)
|
12 (12-13)
|
Child-Pugh Score ( 5-15)
|
6 (6-8)
|
6 (6-8)
|
6 (6-7)
|
0.09
(NS)
|
6 (6-7)
|
6 (6-7)
|
ALB1 (g/dl)
|
2.75±0.32
|
2.63±0.20
|
2.94±0.39
|
0.00
(S)
|
3.28±0.46
|
2.82±0.28
|
H.ALB (g/day)
|
16.99±5.11
|
18.89±3.16
|
14.06±6.09
|
0.00
(S)
|
9.38±6.80
|
15.63±5.01
|
ALB (g/dl)
|
2.72±0.13
|
2.87±0.12
|
2.57±0.13
|
0.04
(NS)
|
2.55±0.11
|
2.57±0.14
|
CRP (mg/dl)
|
34.16±17.93
|
28.38±14.38
|
43.09±19.28
|
0.01
(S)
|
50.55±21.88
|
40.61±17.89
|
SBPmin (mmHg)
|
97.56±12.94
|
103.77±3.15
|
88.41±16.13
|
0.00
(S)
|
54.50±20.69
|
93.55±6.09
|
SBPmax (mmHg)
|
107.56±12.94
|
113.77±3.15
|
98.41±16.13
|
0.00
(S)
|
64.50±20.69
|
103.55±6.09
|
SBPavg (mmHg)
|
105.56±12.94
|
111.77±3.15
|
96.41±16.13
|
0.00
(S)
|
62.50±20.69
|
101.55±6.09
|
%SBPvar
|
9.79%±3.10%
|
8.96%±0.26%
|
11.04%±4.61%
|
0.00
(S)
|
18.67%±10.00%
|
9.88%±0.64%
|
DBPmin (mmHg)
|
52.31±13.19
|
58.64±3.23
|
42.99±16.46
|
0.00
(S)
|
38.40±21.09
|
48.23±6.25
|
DBPmax (mmHg)
|
66.89±13.64
|
73.44±3.30
|
57.26±17.02
|
0.00
(S)
|
21.50±21.87
|
62.68±6.44
|
DBPavg (mmHg)
|
60.34±13.19
|
66.65±3.20
|
51.03±16.47
|
0.00
(S)
|
16.40±21.09
|
56.27±6.24
|
%DBPvar
|
27.64%19.64%
|
22.52%±1.10%
|
35.18%±29.37%
|
0.00
(S)
|
90.11%±56.98%
|
26.86%±3.36%
|
MAPmin (mmHg)
|
67.79±11.71
|
73.77±3.15
|
58.99±13.98
|
0.00
(S)
|
28.90±14.22
|
63.55±6.09
|
MAPmax (mmHg)
|
81.02±12.15
|
87.04±3.16
|
72.14±14.81
|
0.00
(S)
|
40.40±16.28
|
76.95±6.14
|
MAPavg (mmHg)
|
75.70±12.13
|
81.77±3.15
|
66.76±14.70
|
0.00
(S)
|
35.20±16.06
|
71.55±6.09
|
%MAPvar
|
18.29%±5.36%
|
16.34%±0.65%
|
21.17%±7.54%
|
0.00
(S)
|
36.96%±11.48%
|
18.77%±1.78%
|
TC (Cal/day)
|
1327.32±261.96
|
1357.56±270.23
|
1280.54±243.32
|
0.58
(NS)
|
1181.86±269.47
|
1313.43±227.52
|
PD (g/100Cal/day)
|
3.64±0.63
|
3.72±0.74
|
3.50±0.36
|
0.00
(S)
|
3.46±0.42
|
3.52±0.35
|
Values are presented as mean±standard deviation
using one sample T-test and independent T-test, as number (%) using chi
square test, or us median (range) using Mann Whitney U-test.
|
N: Number of study’s critically ill patients.
ALB: Albumin level.
H.ALB: Human albumin.
|
DBP: Diastolic blood pressure.
SBP: Systolic blood pressure.
MAP: Mean arterial pressure.
|
S: Significant (P-Value <0.05).
GCS: Glasgow coma scale.
Cal: Kcal.
NE: Norepinephrine.
|
TC: Total calories.
PD: Protein density.
CRP: C-reactive protein.
NS: Non-significant (P-Value >0.05).
|
|
|
|
|
|
|
|
|
Our studied three prognosticators of
%SBPvar, %MAPvar, and %DBPvar were
significantly lower in survivors in compared with non survivors (8.96%±0.26%, 16.34%±0.65%, and 22.52%±1.10% versus 11.04%±4.61%,
21.17%±7.54%, and 35.18%±29.37%, respectively). There were insignificant differences
between the two tested groups regarding average child-Pugh score, average
Glasgow coma scale (GSC), average NE infusion rate, and total calories (TC)
inputs. Demographics, admission
co-morbidities and class, anthropometrics, and follow-up comparison data of the
study’s critically ill patients are fully summarised in Table 1 and Table 2,
respectively. Table 3 shows the optimal cut-off point, TPR, TNR, YI, PPV, NPV,
and AI of the tested prognostic indicators. The best cut-off values for %SBPvar, %MAPvar,
and %DBPvar in our study were 12.26%, 18.49%, and 105.11% for overall 28-day ICU
mortality. The area under curve of (ROC) AUROC of %MAPvar (0.818;
95% CI, 0.738-0.897) was significantly greater than those of %SBPvar (0.769;
95% CI, 0.678-0.859) and %DBPvar (0.265; 95%, 0.179-0.350). Fig 1
illustrates the ROC curve analysis for the three tested prognosticators of the
overall 28-day ICU mortality.
Table III: Optimal cut-off
point, sensitivity, specificity, positive and negative predictive values, Youden
and accuracy indices of the three tested prognosticators of %SBPvar,
%MAPvar, and %DBPvar for overall 28-day ICU mortality.
|
Prognosticator
|
Cut-off
|
TPR
|
FPR
|
YI
|
TNR
|
PPV
|
NPV
|
AI
|
AUCROC
|
p-value
|
%SBPvar
|
12.26%
|
83.90%
|
38.90%
|
45.00%
|
61.10%
|
58.23%
|
85.44%
|
70.05%
|
0.769
|
<0.05 (S)
|
%MAPvar
|
18.49%
|
87.10%
|
28.20%
|
58.90%
|
71.80%
|
66.63%
|
89.59%
|
77.81%
|
0.818
|
<0.05 (S)
|
%DBPvar
|
105.11%
|
15.60%
|
0.00%
|
15.60%
|
100%
|
100%
|
64.70%
|
66.86%
|
0.265
|
<0.05 (S)
|
%SBPvar: Percentage variation of systolic blood pressure.
%MAPvar: Percentage variation of mean arterial pressure.
%DBPvar: Percentage variation of diastolic blood pressure.
TPR: True positive rate (sensitivity)
FPR: False positive rate.
YI: Youden index.
|
PPV: Positive predictive value.
NPV: Negative predictive value.
AI: Accuracy index.
TNR: True negative ratio (specificity).
AUCROC: Area under curve of receiver operating characteristic.
ICU: Intensive care unit.
|
Discussion
The present study included septic
mechanically ventilated critically ill patients who were taking norepinephrine
as a vasopressor at an overall average rate of 9.53±1.79
mcg/min. To the best of our knowledge, this is the first study that compare the
prognosticating performance of three pressure parameters of SBP, MAP, and DBP
using there’s percentage variations based on the concept of dynamic changes,
instabilities, and high acuities of septic critically ill patients.[13-16]
Vital sign dependent on blood pressure (BP) emphasises current
physiologic no-cost bedside triage dynamic rather than static tools that can be
used at any time for triage decisions and appropriately assigning a higher priority to sicker septic
patients in the context of
ever-shrinking resources, early stratification with fast, affordable, valid,
reliable, and discriminative predictive tools while waiting for
the results of other diagnostics.[17-20] After careful
analysis of the data, %MAPvar demonstrated significantly higher
sensitivity, performance, negative predictive value, and accuracy than %SBPvar
followed by %DBPvar (87.10%, 58.90%, 89.59%, and 77.81%
versus 83.90%, 45.00%, 85.44%, and 70.05% versus 15.60%, 15.60%, 64.70%, and
66.86%, respectively). This study demonstrates a vast difference
in predictive values of BP percentage
variations, possibly due to the fact that fluid resuscitation and norepinephrine,
which were primarily used in these septic mechanically ventilated critically
ill studied patients, gives rise to alterations of physiological parameters of
heart rate (HR), stroke volume (SV), cardiac output (CO), and systemic vascular
resistance (SVR), making the BP percentage variations especially %MAPvar
indicator a realistic reflection of the septic patients and a more reliable
predictive prognosticator compared to with other non-dynamic indicators such as
CRP and pro-calcitonin, lactate, and white blood cells (WBCs).[21-24]
In summary, %MAPvar prognosticator and %SBPvar were
an effective, no-cost bedside modalities, and discriminative prognosticators
with realistic, reliable, and readily available red flag bedside assessment
tools which had high sensitivity, performance, and accuracy to predict early,
late, and overall 28-day ICU mortality in septic mechanically ventilated
critically ill patients who are taking norepinephrine as a vasopressor.[25-27]
This study is limited by its retrospective
design, using single-centre data, including only septic mechanically ventilated
ICU patients. Nonetheless, our centre is an experienced and high-volume unit,
so our data may be useful in other centres. A larger,
multisite, and prospective study is needed to control for multiple confounders.
References
1. Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: a challenge for patients
and hospitals. NCHS Data Brief. 2011;62:1–8.
2. De Backer D, Dorman T. Surviving sepsis guidelines: a continuous move toward better care
of patients with sepsis. JAMA. 2017;317:807–808.
3. Maheswari KS, Munson S, Nathanson B, Hwang S, Khanna A. Relationship between intensive care unit
hypotension and morbidity in patients diagnosed with sepsis. Crit Care. 2018;22(Suppl):1.
4. Kellum J, Lameire N, Co-Chairs WG. Kidney disease: improving global outcomes
(KDIGO). KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
5. Dowton SB, Colten HR. Acute phase reactants in inflammation and infection. Semin Hematol 1988; 25:84–90.
6. Simon L, Gauvin F, Amre DK et al. Serum procalcitonin and C-reactive protein levels as markers
of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206–17.
7.Mitchell G.F. Arterial stiffness and hypertension. Hypertension. 2014;64:13–18.
8. Whitworth J.A., World Health Organization. International Society of
Hypertension Writing Group 2003 World Health Organization (WHO)/International
Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003;21:1983–1992.
9. Shriram R., Wakankar A., Daimiwal N., Ramdasi D. Continuous cuffless blood pressure monitoring
based on PTT; Proceedings of the 2010 International Conference on
Bioinformatics and Biomedical Technology (ICBBT); Chengdu, China. 16–18 April
2010; pp. 51–55.
10. Marani R., Perri A.G. An intelligent system for continuous blood
pressure monitoring on remote multi-patients in real time. arXiv. 2012. 1212.0651.
11. Ilie B. Portable
equipment for monitoring human functional parameters; Proceedings of the 2010
9th IEEE Roedunet International Conference (RoEduNet); Sibiu, Romania. 24–26
June 2010; pp. 299–302.
12. Goli S., Jayanthi T. Cuff less continuous non-invasive blood pressure measurement
using pulse transit time measurement. Int. J. Recent Dev. Eng. Technol. 2014;2:87.
13. Zimmerman JE, Kramer AA, McNair DS, et al. Acute Physiology and Chronic Health Evaluation
(APACHE) IV: hospital mortality assessment for today’s critically ill
patients. Crit
Care Med. 2006;34(5):1297–1310.
14. Higgins TL, Teres D, Copes WS, et al. Assessing contemporary intensive care unit
outcome: an updated Mortality Probability Admission Model (MPM0-III) Crit Care Med. 2007;35(3):827–835.
15. Tuman KJ, McCarthy RJ, March RJ, et al. Morbidity and duration of ICU stay after cardiac surgery. A model
for preoperative risk assessment. Chest. 1992;102(1):36–44.
16. Cohen J, Guyatt G, Bernard GR, et al. New strategies for clinical trials in patients with sepsis and
septic shock. Crit Care Med. 2001;29(4):880–886.
17. Hug CW, Clifford GD, Reisner AT. Clinician blood pressure documentation of stable intensive care
patients: an intelligent archiving agent has a higher association with future
hypotension. Crit
Care Med. 2011;39(5):1006–1014.
18. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and
septic shock. N Engl J Med. 2001;345(19):1368–1377.
19. Knaus WA, Wagner DP, Draper EA, et al. The Apache-Iii Prognostic System - Risk Prediction of Hospital
Mortality for Critically Ill Hospitalized Adults. Chest. 1991;100(6):1619–1636.
20. Sirio CA, Bastos PG, Knaus WA, et al. Apache-Ii Scores in the Prediction of Multiple
Organ Failure Syndrome. Archives of Surgery. 1991;126(4):528–528.
21. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: a
review of indices used in intensive care. Intensive Care Medicine. 2003;29(3):352–360.
22. Diebel L, Wilson RF, Heins J, Larky H, Warsow K, Wilson S. End-diastolic volume versus pulmonary artery
wedge pressure in evaluating cardiac preload in trauma patients. Journal
of Trauma. 1994;37(6):950–955.
23. Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of
sepsis in adult patients: 2004 Update. Critical Care Medicine. 2004;32(9):1928–1948.
24. Osman D, Ridel C, Ray P, et al. Cardiac filling pressures are not appropriate to
predict hemodynamic response to volume challenge. Critical
Care Medicine. 2007;35(1):64–68.
25. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri
VM, et al. Does dopamine administration in shock
influence outcome? results of the sepsis occurrence in acutely ill patients
(SOAP) Study. Crit
Care Med. 2006;34:589–597.
26. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke
R, et al. Surviving Sepsis Campaign:
international guidelines for management of severe sepsis and septic shock:
2008. Crit
Care Med. 2008;36:296–327.
27. Keegan MT, Gajic O, Afessa B. Severity of illness scoring systems in the
intensive care unit. Crit Care Med. 2011;39:163–169.v